scholarly article | Q13442814 |
P356 | DOI | 10.1136/STI.76.3.183 |
P8608 | Fatcat ID | release_tjicmcdfabf2rdyjuub3nzd6ba |
P932 | PMC publication ID | 1744133 |
P698 | PubMed publication ID | 10961195 |
P5875 | ResearchGate publication ID | 246156589 |
P2093 | author name string | Gay NJ | |
Gopal R | |||
Brown DW | |||
Morgan-Capner P | |||
Vyse AJ | |||
Gibbs T | |||
Slomka MJ | |||
P2860 | cites work | Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera | Q24649122 |
Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type | Q28288314 | ||
Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield | Q33658596 | ||
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection | Q33687109 | ||
The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. | Q33934554 | ||
Genital herpes: review of the epidemic and potential use of type-specific serology | Q33975387 | ||
Surveillance of antibody to measles, mumps, and rubella by age. | Q35703155 | ||
The incidence of Herpesvirus hominis antibody in the population | Q36251747 | ||
Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations | Q36888658 | ||
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world | Q37901326 | ||
High prevalence of herpes simplex virus type 1 in female anogenital herpes simplex in Newcastle upon Tyne 1983-92. | Q39384023 | ||
Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology | Q39394727 | ||
Herpes simplex virus-2 infection. An emerging disease? | Q41717714 | ||
Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. | Q42938618 | ||
Apparent increase in the prevalence of herpes simplex virus type 1 genital infections among women. | Q42947863 | ||
Genital herpes simplex virus type 1 in women. | Q42947977 | ||
HSV type specific antibody tests: patients are ready, are clinicians? | Q42948758 | ||
Sexually transmitted organisms in children and child sexual abuse | Q43440596 | ||
Apparent increase in the prevalence of herpes simplex virus type 1 genital infections among women | Q44327238 | ||
A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes | Q45755988 | ||
Herpes simplex virus type 2 in the United States, 1976 to 1994. | Q45760165 | ||
Cold sores and safer sex | Q68313532 | ||
Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology | Q68453367 | ||
Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections | Q68609805 | ||
Herpes vaccines: spinning a new DISC | Q71922778 | ||
P433 | issue | 3 | |
P921 | main subject | epidemiology | Q133805 |
Herpes simplex virus type 1 | Q655331 | ||
Human herpesvirus 2 | Q18965147 | ||
P304 | page(s) | 183-187 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Sexually Transmitted Infections | Q7458852 |
P1476 | title | The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes | |
P478 | volume | 76 |
Q35530989 | A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica |
Q34152197 | Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review |
Q24646809 | An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection |
Q45072015 | Analysis of the Protective Immunity Induced by Herpes Simplex Virus 1 Strain M3 with an Attenuated Phenotype Due to Mutations in the Viral ul7, ul41, and LAT Genes |
Q40622189 | Antiviral activity of CTC-8 against herpes simplex virus (HSV-1) in cell culture: evidence for a selective antiviral effect via a cellular mechanism. |
Q34918258 | Challenges in genital herpes simplex virus management |
Q63766995 | Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions |
Q55715610 | Chester Chronicles: Paddy. |
Q36607303 | Clinical assessment of assays for diagnosis of herpes simplex infection |
Q44282977 | Comparison between turnaround time and cost of herpes simplex virus testing by cell culture and polymerase chain reaction from genital swabs |
Q45401404 | Comparison of the dynamics and correlates of transmission of Herpes Simplex Virus-1 (HSV-1) and Varicella-Zoster Virus (VZV) in a sample of the Israeli population |
Q35025766 | Current treatments and perceptions of genital herpes: a European-wide view. |
Q33882404 | Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control |
Q43950544 | Detection of HSV-2 in genital ulcers from STD patients in Dar es Salaam, Tanzania |
Q41673194 | Development of a time-resolved fluorescence immunoassay for herpes simplex virus type 1 and type 2 IgG antibodies. |
Q36463219 | Diagnostics for herpes simplex virus: is PCR the new gold standard? |
Q59176523 | Difficultés d’interprétation de la sérologie herpétique |
Q35780697 | Efficacy results of a trial of a herpes simplex vaccine |
Q40079770 | Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar |
Q33570474 | Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016. |
Q36930524 | Genital HSV-1 infections |
Q34626947 | Genital herpes simplex virus infection in the adolescent: special considerations for management |
Q44681310 | Genital herpes: an Internet-based risk survey. |
Q40456112 | Herpes Simplex Virus Type 1 Shedding in Tears and Nasal and Oral Mucosa of Healthy Adults. |
Q37663350 | Herpes simplex virus infection in neonates and young infants with sepsis. |
Q44285124 | Herpes simplex virus infections |
Q36092857 | Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period |
Q63740003 | Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics |
Q61800864 | Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions |
Q35530166 | Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? |
Q45602763 | Herpes simplex virus type 2 and recurrent meningitis |
Q24647763 | Herpes simplex virus type 2 seroprevalence in Korea: rapid increase of HSV-2 seroprevalence in the 30s in the southern part |
Q51239417 | How safe is safer sex? High levels of HSV-1 and HSV-2 in female sex workers in London. |
Q90740831 | Human labour is associated with altered regulatory T cell function and maternal immune activation |
Q47552397 | Implication of Soluble Forms of Cell Adhesion Molecules in Infectious Disease and Tumor: Insights from Transgenic Animal Models |
Q33801850 | Improving the care of patients with genital herpes |
Q39613297 | Incidence of serum antibody titers against herpes simplex virus in Japanese patients |
Q33856742 | Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years |
Q51804483 | Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study. |
Q33582145 | New concepts in understanding genital herpes |
Q26746041 | Optimal management of genital herpes: current perspectives |
Q30478605 | Oral shedding of herpes simplex virus type 2. |
Q24670332 | Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia |
Q35073056 | Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania |
Q24654706 | Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey |
Q51396762 | Public awareness and knowledge of herpes labialis. |
Q24550624 | Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada |
Q78607672 | Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history |
Q64060908 | Risk factors for herpes simplex virus type-1 infection and reactivation: Cross-sectional studies among EPIC-Norfolk participants |
Q37006121 | Risk of herpes simplex virus type 2 acquisition increases over early adulthood: evidence from a cohort study |
Q35530858 | Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. |
Q24791873 | Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study |
Q45730664 | Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection |
Q37583223 | Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan |
Q45514972 | Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former East and West Germany, 1997-1998. |
Q34576295 | Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey |
Q45410426 | Seroprevalence of herpes simplex virus type 2 in multiple sclerosis |
Q42261512 | Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. |
Q34313806 | Sorting out the new HSV type specific antibody tests |
Q35551858 | Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. |
Q39927510 | The Natural History of Human Polyomaviruses and Herpesviruses in Early Life--The Rhea Birth Cohort in Greece |
Q92726970 | The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies |
Q40451304 | The epidemiological contribution to the preparation of field trials for HIV and STI vaccines: objectives and methods of feasibility studies. |
Q56561856 | The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions |
Q38322744 | The epidemiology of sexually transmitted infections in the UK: impact of behavior, services and interventions. |
Q38062478 | The miRNAs of herpes simplex virus (HSV). |
Q24679583 | The seroepidemiology of herpes simplex virus type 1 and 2 in Europe |
Q36930412 | Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland |
Q34868359 | Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision |
Q24669976 | Viral meningitis |
Search more.